Detalles de la búsqueda
1.
Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy.
Cancer Chemother Pharmacol
; 88(5): 813-823, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34309735
2.
Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics?
J Chemother
; 32(6): 310-322, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32441565
3.
Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum-based chemoradiotherapy treatment.
Head Neck
; 41(8): 2704-2715, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30973677
4.
Long Survival and Severe Toxicity Under 5-Fluorouracil-Based Therapy in a Patient With Colorectal Cancer Who Harbors a Germline Codon-Stop Mutation in TYMS.
Mayo Clin Proc
; 90(9): 1298-303, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26210704
5.
X-ray cross-complementing group 1 and thymidylate synthase polymorphisms might predict response to chemoradiotherapy in rectal cancer patients.
Int J Radiat Oncol Biol Phys
; 82(1): 138-44, 2012 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21167658
6.
Anti-EGFR therapy in first-line colorectal cancer.
Expert Rev Anticancer Ther
; 11(10): 1499-503, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21999123
7.
Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin regimen in patients with metastatic colorectal cancer.
Pharmacogenomics
; 12(3): 433-42, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21449681
8.
Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response.
Pharmacogenomics
; 11(6): 747-61, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20504250
Resultados
1 -
8
de 8
1
Próxima >
>>